enGene Holdings Statistics
Total Valuation
enGene Holdings has a market cap or net worth of $462.23 million. The enterprise value is $219.74 million.
Important Dates
The last earnings date was Monday, March 9, 2026, before market open.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
enGene Holdings has 66.99 million shares outstanding. The number of shares has increased by 23.40% in one year.
| Current Share Class | 66.99M |
| Shares Outstanding | 66.99M |
| Shares Change (YoY) | +23.40% |
| Shares Change (QoQ) | +30.91% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 42.10% |
| Float | 26.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.75, with a Debt / Equity ratio of 0.12.
| Current Ratio | 11.75 |
| Quick Ratio | 11.36 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.95 |
Financial Efficiency
Return on equity (ROE) is -46.07% and return on invested capital (ROIC) is -27.06%.
| Return on Equity (ROE) | -46.07% |
| Return on Assets (ROA) | -25.63% |
| Return on Invested Capital (ROIC) | -27.06% |
| Return on Capital Employed (ROCE) | -40.88% |
| Weighted Average Cost of Capital (WACC) | 2.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.49M |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.11% in the last 52 weeks. The beta is -0.28, so enGene Holdings's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | +39.11% |
| 50-Day Moving Average | 9.16 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 30.91 |
| Average Volume (20 Days) | 600,888 |
Short Selling Information
The latest short interest is 1.24 million, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.50M |
| Short % of Shares Out | 1.84% |
| Short % of Float | 4.67% |
| Short Ratio (days to cover) | 5.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -127.74M |
| Pretax Income | -122.46M |
| Net Income | -122.44M |
| EBITDA | -127.14M |
| EBIT | -127.74M |
| Earnings Per Share (EPS) | -$2.22 |
Full Income StatementBalance Sheet
The company has $275.95 million in cash and $33.46 million in debt, with a net cash position of $242.48 million or $3.62 per share.
| Cash & Cash Equivalents | 275.95M |
| Total Debt | 33.46M |
| Net Cash | 242.48M |
| Net Cash Per Share | $3.62 |
| Equity (Book Value) | 281.55M |
| Book Value Per Share | 4.20 |
| Working Capital | 264.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$102.45 million and capital expenditures -$1.34 million, giving a free cash flow of -$103.79 million.
| Operating Cash Flow | -102.45M |
| Capital Expenditures | -1.34M |
| Depreciation & Amortization | 596,000 |
| Net Borrowing | 1.25M |
| Free Cash Flow | -103.79M |
| FCF Per Share | -$1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
enGene Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.40% |
| Shareholder Yield | -23.40% |
| Earnings Yield | -26.49% |
| FCF Yield | -22.45% |
Analyst Forecast
The average price target for enGene Holdings is $21.00, which is 204.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $21.00 |
| Price Target Difference | 204.35% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
